NASDAQ: RNTX · Biotechnology
Over the past week, Rein Therapeutics (RNTX) pulled in about 27 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 0% bullish across the tracked sources. Wall Street is more constructive, with 2 of 2 analysts rating RNTX a buy.
There is little buzz around RNTX this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 0% to X at 0%. No other tracker puts the two side by side.
Across 2 analysts the consensus is a Strong Buy: 2 buy calls against 0 sell, with an average 12-month price target of $6.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 2 sources broadly agree, so the read is a Sell.
Analysts sit 100 points above the crowd average of 0%, the professionals are more constructive than retail. The split is inside the crowd: X reads 0% bullish while News sits at 0%, a 0-point spread that single-source trackers miss.
Over the 30-day window, Rein Therapeutics (RNTX) buzz held subdued around 32.4 while the price drifted down 1.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 390K shares. Updated Sep 26, 2026. Over the last 7 trading days, RNTX lost 5.2%. Buzz activity in the recent week averaged 39.0 and was variable, swinging between 25.7 and 53.8. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 2 of the 8 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for RNTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RNTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (2 / 0 / 0) |
| Crowd bullish (7d) | 0% |
| Avg price target | $6.00 |
| Most bullish source | X, 0% |
| Most bearish source | News, 0% |
| Sentiment spread | 0 pts |
| Mentions (7d) | 27 |
| Market cap | $64.2M |
| EPS · Beta | -$1.68 · 1.4 |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Rein Therapeutics (RNTX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 0% bullish across 2 active sources. Those sources contribute 27 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads bearish on Rein Therapeutics (RNTX), averaging 0% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 0% bullish and News at 0%, a 0-point spread. On the professional side, 2 of 2 analysts rate RNTX a buy.
Of the 2 analysts covering Rein Therapeutics (RNTX), 2 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $6.00. That puts the street ahead of the crowd, which averages 0% bullish.
Rein Therapeutics (RNTX)'s cross-source average is bearish at 0% bullish. All 2 tracked sources lean bearish. News reads 0% bullish and x coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Rein Therapeutics (RNTX) at 0% bullish. All 2 tracked sources lean bearish. The most bearish reading is x at 0% bullish. 3-day activity momentum is rising across X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 27 mentions (100% of total volume). The cross-source average is bearish at 0% bullish, while x is the only source with rising 3-day activity. All 2 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RNTX's sell signal at 93/100 conviction reflects a bearish cross-source average at 0% bullish. All 2 tracked sources lean bearish. It is a research shortcut, not financial advice.
The RNTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key